Medical Innovations for a Healthier Future

Bringing Tomorrow Today

Discover the future of cancer treatment with SEF Immuno-Chemo, a revolutionary therapy delivering successful remissions without the toxicity associated with traditional chemotherapy.

Dr. Kenneth Matsumura—the visionary who pioneered this groundbreaking cancer therapy—is now changing the landscape of treatment. His novel approach has garnered international acclaim, and now, Dr. Matsumura is being sought after worldwide to share his expertise. As a leading authority in the field, he is on a mission to teach medical professionals globally, ensuring that the transformative impact of his innovative therapy reaches patients far and wide. His cancer therapy instruction will focus on lung and breast cancer, recognizing them as the foremost contributors to global cancer-related mortality. This emphasis stems from the current scrutiny faced by existing treatments for their limited achievements, necessitating innovative approaches and advancements in the field. Unfortunately, the 2-year training program will restrict Dr. Matsumura’s availability to conduct SEF Chemo at our Berkeley clinic, but Dr. Matsumura's commitment to spreading knowledge marks a new chapter in the fight against cancer, promising hope and progress on a global scale.

Remarkable Achievements

Established in 1962, ALIN Foundation is one of the oldest bio-tech organization in the world. For over half a century, ALIN Foundation has developed lifesaving medical treatments for the 5 leading causes of fatalities in the world — heart attack, cancer, diabetes, infectious diseases, and liver failure. Each development represents a stunning breakthrough in its field.

Our Medical Innovations

ALIN Foundation promotes a kind & just world

ALIN Foundation, named for our bio-artificial liver invention, is unique in that it operates as a charitable foundation with for-profit entities that return funding from our medical innovations. To date, ALIN has received no government or charitable assistance.

While ALIN is a world leader in breakthrough medical treatments, we have a profound interest in the general welfare of people around the world. ALIN funds social justice programs to create a kind and just world from its medical revenues and practices affirmative action to provide economic opportunities, equally, to all.

“Innovation doesn’t always come in the form of a new product or new technology. Sometimes it’s about a new way to address an old problem.”

— Dr. Matsumura, CEO of ALIN Foundation

News

2023 Biotech Innovations & Trends

Read more

Celebrating 60 Years of Innovation

Read more

Novel Infectious Containment Units

Read more

Actor William Hurt Praises SEF Chemo

Read more

Questions?